SCHEMBL28864069

SCHEMBL28864069

NNC(=O)c1ncnc2nc[nH]c12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PI4KA P42356 2/20 0.49
▸ PI4K2B Q8TCG2 2/20 0.49
▸ PI4K2A Q9BTU6 2/20 0.49
▸ PI4KB Q9UBF8 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ XDH P47989 1/20 0.49
▸ LRRK2 Q5S007 1/20 0.49
▸ BRD4 O60885 2/20 0.48
▸ TSHR P16473 2/20 0.47
▸ CYP3A4 P08684 1/20 0.46
▸ MKNK1 Q9BUB5 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ NT5C2 P49902 1/20 0.44
▸ TOP2A P11388 1/20 0.43
▸ BRAF P15056 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28243803 0.85 BRD4 (0.49) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL1749123 0.81 PI4KA (0.53) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL27796380 0.79 PI4KA (0.52) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL2843842 0.79 TOP2A (0.51) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL5241436 0.77 TSHR (0.54) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL4520816 0.77 PI4KA (0.48) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL31456991 0.77 MKNK1 (0.57) LMNALRRK2BRD4TSHRMKNK1
SCHEMBL27376395 0.77 MKNK1 (0.57) LMNALRRK2BRD4TSHRMKNK1
SCHEMBL30484606 0.77 TSHR (0.50) PI4KAPI4K2BPI4K2API4KBLMNA
SCHEMBL20207317 0.75 DYRK1A (0.46) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602825-A Purine compounds having anticancer activity 中央研究院 2018-09-28 — — CN disclosed
Send feedback